Previous Page  14 / 16 Next Page
Information
Show Menu
Previous Page 14 / 16 Next Page
Page Background

Page 47

Volume 13

Journal of Orthopaedics Trauma Surgery & Related Research

Arthroplasty 2018

September 24-25, 2018

Arthroplasty

September 24-25, 2018 London, UK

11

th

International Conference on

Jonathan Boyd, J Arthroplasty 2018, Volume 13

Clinical application: The changing landscape in allografts

Jonathan Boyd

American Association of Tissue Banks, USA

Processing and classification of most human cell and cellular based tissue products has remained the same for decades. The basic

homologous function of transplanted osteocondrial allografts and total joint replacements utilizing allografts has fundamentally

followed suite. However, guidance from the United States Food and Drug Administration may shift some of these approaches and

the grafts which are available for implantation or transplantation. The purpose of this presentation is to review and evaluate changes

in processing, distribution, classifications and possible shift in the United States tissue banking community to medical devices and

biologics as a result of this guidance providing and developing different options in arthroplasty. The Learning Objectives and expected

outcomes of this study is to Outline previous guidance and regulation, Summarize the current options and limitations in human cell

and cellular based tissue products, to review potential changes in guidance and regulation and finally to summarize the impact and

potential changes to arthroplastic allograft application

BoydJ@aatb.org